enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Roche joins race for obesity drugs with $2.7 billion Carmot deal

    www.aol.com/news/roche-enters-obesity-drug...

    Roche agreed to take over obesity drug developer Carmot Therapeutics for $2.7 billion, joining a list global contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk ...

  3. Roche shares knocked by concern over side effects in obesity ...

    www.aol.com/news/roche-shares-drop-side-effects...

    Roche shares were trading 3.5% down by 0940 GMT, the second biggest faller on the pan-European STOXX 600 index, after the company presented details on the trial with once-daily pill CT-996 late on ...

  4. Roche open to big acquisitions 'if it makes scientific and ...

    www.aol.com/news/roche-open-big-acquisitions...

    Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker unencumbered by its $20.7 billion deal last year to buy back its ...

  5. Roche - Wikipedia

    en.wikipedia.org/wiki/Roche

    Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue [6] and the leading provider of cancer treatments globally. [7] [8] In 2023, the company’s seat in Forbes Global 2000 was 76. [9]

  6. Corporate action - Wikipedia

    en.wikipedia.org/wiki/Corporate_action

    Examples of corporate actions include stock splits, dividends, mergers and acquisitions, rights issues, and spin-offs. [ 1 ] Some corporate actions such as a dividend (for equity securities) or coupon payment (for debt securities) may have a direct financial impact on the shareholders or bondholders; another example is a call (early redemption ...

  7. List of largest pharmaceutical mergers and acquisitions

    en.wikipedia.org/wiki/List_of_largest...

    Valeant raised its unsolicited offer for Allergan a second time, to $53.3 billion, increasing the cash portion of the bid in an effort to win the backing of the company, with the cash-and-stock portion of the bid valuing each Allergan share at $179.25.

  8. 4 Dividend Stocks to Double Up on Right Now - AOL

    www.aol.com/finance/4-dividend-stocks-double-now...

    Dividend-Paying Status. Average Annual Total Return, 1973-2023. Dividend growers and initiators. 10.19%. Dividend payers. 9.17%. No change in dividend policy

  9. Return on equity - Wikipedia

    en.wikipedia.org/wiki/Return_on_equity

    The return on equity (ROE) is a measure of the profitability of a business in relation to its equity; [1] where: . ROE = ⁠ Net Income / Average Shareholders' Equity ⁠ [1] Thus, ROE is equal to a fiscal year's net income (after preferred stock dividends, before common stock dividends), divided by total equity (excluding preferred shares), expressed as a percentage.